Valproic Acid: all 264 studies that test it

Page 3 of 3. Open to participants first (17), then studies with results posted, then the rest; newest registration first within each.

• Phase I/II Trial of Valproic Acid and Karenitecin for MelanomaTerminatedNCT00358319Phase 1/2
• Comparison of Immediate vs Gradual Switch to Divalproex in Adults With Intellectual DisabilityCompletedNCT00347152Not applicable
• A Comparison Study of the Efficacy and Tolerability of Depakote ER and Depakote DRCompletedNCT00334347Phase 4
• Depakote Extended Release (ER) Versus Seroquel for Agitated Behaviors in Nursing Home Care Unit Patients With DementiaTerminatedNCT00315900Phase 3
• Study of Valproic Acid to Treat HIV Infected AdultsTerminatedNCT00312546Phase 1
• Risperidone Alone Vs. Risperidone Plus Valproate in the Treatment of Patients With Schizophrenia and HostilityCompletedNCT00308360Phase 4
• A Pharmacokinetic Study to Compare the Dosing of Valproic Acid in Subjects With Different Body WeightsTerminatedNCT00298857Phase 4
• Valproic Acid and Its Effects on HIV Latent ReservoirsCompletedNCT00289952Phase 2
• Study of Divalproex Extended Release Monotherapy in Ambulatory Bipolar Spectrum Disorder With Moderate-to-Severe Hypomania or Mild ManiaCompletedNCT00278772Phase 3
• Safety Study of Sodium Divalproate in Bipolar Disorder in AdolescentsCompletedNCT00271258Phase 3
• VALID : VAlproate Versus LIthium in Bipolar DisordersCompletedNCT00264173Phase 4
• Phase I Trial of Valproic Acid and Epirubicin in Solid Tumor MalignanciesCompletedNCT00246103Phase 1
• A Study of the Effectiveness and Safety of Topiramate Compared With a Standard Therapy in Patients Newly Diagnosed With EpilepsyCompletedNCT00236717Phase 3
• Medication Strategies for Treating Aggressive Behavior in Youth With Attention Deficit Hyperactivity DisorderCompletedNCT00228046Phase 4
• Depakote-ER for Depressive and Bipolar DepressionCompletedNCT00226343Phase 4
• Depakote ER in Borderline Personality DisorderCompletedNCT00222482Not applicable
• Efficacy of Valproate in Peripheral Neuropathic PainTerminatedNCT00221637Phase 2/3
• Lithium Versus Divalproex for Treating Pediatric Bipolar DisorderCompletedNCT00221429Phase 3
• Divalproex Sodium (Depakote) for Explosive Tempers in Adolescents and AdultsCompletedNCT00218114Phase 3
• Effectiveness of Divalproex Sodium (Depakote) in Treating Children With Temper Outbursts and Severe Mood SwingsCompletedNCT00217932Phase 2
• Divalproex Sodium ER in Adult AutismCompletedNCT00211796Phase 4
• Comparing Compliance, Tolerability, Efficacy and Adverse Events in Bipolar Tients From Valproic Acid to Depakote ERCompletedNCT00211250Phase 4
• A Comparison of Two Standard Therapies in the Management of Dementia With AgitationCompletedNCT00208819Phase 4
• Depakote ER Therapy for Mania Comorbid With Substance AbuseCompletedNCT00208195Phase 4
• Six Month Trial of Lamotrigine vs. Sodium Valproate for Treatment of Mixed ManiaCompletedNCT00206778Phase 2
• Open-Label Depakote ER in Patients With Bipolar I or II Depression and Alcohol Abuse or DependenceWithdrawnNCT00204503Phase 2
• Divalproex ER vs. Risperidone for Bipolar Disorder With Comorbid Substance Use DisorderCompletedNCT00203528Phase 4
• Maintenance Phase Treatment With Divalproex for Post Traumatic Stress DisorderTerminatedNCT00203385Phase 4
• Placebo Controlled Trial of Depakote ER in Alcohol Dependent Patients With Mood and/or Anxiety SymptomsCompletedNCT00202514Phase 2/3
• Safety And Efficacy Study Of Depakote ER To Treat Pediatric Bipolar DisorderCompletedNCT00199966Phase 4
• Study of Depakote for Behavioral and Psychological Symptoms in DementiaStatus unknownNCT00197834Phase 1
• Study Designed to Evaluate the Safety of Prophylactic Depakote ER in the Treatment of Adolescents With MigraineCompletedNCT00195806Phase 3
• A Study for the Treatment of Mania Associated With Bipolar I Disorder in Children and AdolescentsCompletedNCT00195780Phase 3
• Evaluate the Safety of Depakote Extended Release Tablets in the Treatment of Mania Associated With Bipolar Disorder in Children and AdolescentsCompletedNCT00195767Phase 3
• A Phase III Open-Label, Multi-Center, Long-Term Extension Study of Depakote ER in Subjects Who Either Completed or Prematurely Discontinued Due to Ineffectiveness From Study M02-488.CompletedNCT00195754Phase 3
• The Safety and Efficacy of Divalproex Sodium Extended-Release Tablets in Migraine Prophylaxis: A Study in AdolescentsCompletedNCT00195741Phase 3
• Treatment With ATRA-IV and Depakote in Patients With Advanced Solid Tumor MalignanciesTerminatedNCT00195156Phase 1
• Study of Depakote ER for the Treatment of Mania in Children Ages 6-12 With Bipolar DisorderCompletedNCT00181727Phase 4
• Valproic Acid in the Induction of EBV Lytic Cycle Antigen Expression in Nasopharyngeal CarcinomaWithdrawnNCT00181220Phase 1
• Differentiation Induction in Acute Myelogenous LeukemiaCompletedNCT00175812Phase 1/2
• Study of Efficacy of Sodium Valproate in Therapy of Bronchial AsthmaCompletedNCT00153270Phase 4
• Seroquel in Acute Mania: Study to Investigate if Valproate Add-On Therapy is Superior to Quetiapine Monotherapy in Acutely Manic PatientsTerminatedNCT00139074Phase 4
• Hormone Profiles in Adults With Newly Diagnosed EpilepsyStatus unknownNCT00137709Phase 4
• Trial of Sodium Valproate in Amyotrophic Lateral SclerosisCompletedNCT00136110Phase 3
• Efficacy and Safety of Quetiapine Fumarate (SEROQUEL®) in the Treatment of Alcohol Dependency in Patients With Bipolar DisorderCompletedNCT00114686Phase 3
• Decitabine With or Without Valproic Acid in Treating Patients With Relapsed or Refractory Non-Hodgkin's LymphomaCompletedNCT00109824Phase 1
• Divalproex Sodium in the Treatment of PTSD (Post-Traumatic Stress Disorder)CompletedNCT00108576Phase 3
• Valproic Acid in Treating Young Patients With Recurrent or Refractory Solid Tumors or CNS TumorsCompletedNCT00107458Phase 1
• A Study for Treatment of Partial Seizures in ChildrenCompletedNCT00102713Phase 3
• Effects of Lithium and Divalproex'on Brain-Derived Neurotrophic Factor in Huntington's DiseaseCompletedNCT00095355Phase 2
• Olanzapine vs. Comparator and Placebo in the Treatment of Patients With Bipolar I DisorderCompletedNCT00094549Phase 4
• Effect of Lithium and Divalproex in Alzheimer's DiseaseCompletedNCT00088387Phase 2
• Decitabine and Valproic Acid in Treating Patients With Non-Small Cell Lung CancerCompletedNCT00084981Phase 1
• Efficacy and Safety of Seroquel Plus Mood Stabilizer in the Maintenance of Bipolar I DisorderCompletedNCT00081380Phase 3
• Decitabine and Valproic Acid in Treating Patients With Refractory or Relapsed Acute Myeloid Leukemia or Previously Treated Chronic Lymphocytic Leukemia or Small Lymphocytic LymphomaCompletedNCT00079378Phase 1
• Valproic Acid in Treating Patients With Kaposi's SarcomaCompletedNCT00075777Not applicable
• Phase I/II Study of Decitabine and Valproic Acid in Relapsed/Refractory Leukemia or Myelodysplastic SyndromesCompletedNCT00075010Phase 1/2
• A Study of the Safety and Efficacy of Depakote Sprinkle Capsules in the Treatment of Partial Seizures in ChildrenTerminatedNCT00067431Phase 3
• An Outpatient Study of the Effectiveness and Safety of Depakote ER in the Treatment of Mania/Bipolar Disorder in Children and AdolescentsCompletedNCT00067262Phase 3
• Valproate Response in Aggressive Autistic AdolescentsStatus unknownNCT00065884Phase 3
• An Inpatient Study of the Effectiveness and Safety of Depakote ER in the Treatment of Mania/Bipolar DisorderCompletedNCT00060905Phase 3
• Phase III Double Blind Trial of Valproate Sodium for Prophylaxis of Post Traumatic SeizuresCompletedNCT00004817Phase 3
• The Effects of Valproic Acid on Zidovudine Glucuronidation and Pharmacokinetics in HIV-Infected Patients.CompletedNCT00000629Phase 1
• Drug Treatment for Alcoholics With Bipolar DisorderCompletedNCT00000439Phase 2

← Valproic Acid overview